- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03756363
The Effect of Solvent Usage on Post-treatment Pain
Postoperative Pain After Removal of Gutta-percha From Root Canals in Endodontic Retreatment Using a Solvent
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Scientific literature contains a few studies regarding the amount of apically extruded debris caused by solvent or solvent free use of rotary instruments. It was reported that the use of ProTaper retreatment instruments in combination with gutta-percha solvent reduced the amount of apically extruded debris compared to their solvent free use. Nevertheless,no clinical evidence has been yet published regarding the comparison of postoperative pain after removal of the root canal fillings with or without solvent. The aim of this study was to evaluate the effect of combined usage of ProTaper retreatment instruments and gutta-percha solvent, on the postoperative pain intensity after retreatment. The adult patients (18-59 ages) who referred to Department of Endodontics with a diagnose of failed root canal treatment were examined radiographically and clinically. Endodontically treated, clinically asymptomatic, single-rooted teeth with one canal exhibiting chronic periapical infection were included. A hundred cases who matched the determined criteria were selected and randomly allocated to two groups:
Non-solvent Group (n=50):
ProTaper retreatment instruments were used in combination with with X-Smart electric motor for the removal of root canal fillings.
Solvent Group (n=50):
ProTaper retreatment instruments were used with the abovementioned technique but in combination with a gutta-percha solvent
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Van, Turkey, 65080
- Ozgur Genc Sen
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Systemically healthy patient who has a failed root canal treatment.
- Asymptomatic single rooted teeth that had an initial root canal filling diagnosed with chronic apical periodontitis.
- Patients agreed to parcitipate in the study
Exclusion Criteria:
- Overfilled teeth,
- teeth with intraradicular posts,
- existence of a sinus tract,
- consumption of antibiotics or analgesics within one month,
- pregnancy,
- history of trauma,
- traumatic occlusion
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Non-solvent
Non-solvent use of a rotary retreatment system
|
Root canal filling removal using ProTaper retreatment instruments.
Single session retreatment procedures.
|
|
Experimental: Solvent
Solvent use in combination with a rotary retreatment system
|
Root canal filling removal using ProTaper retreatment instruments in combination with a gutta percha solvent.
Single session retreatment procedures.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Postoperative pain after removal of gutta-percha with or without solvent
Time Frame: 24 hours postoperatively
|
Pain intensity was evaluated at 24 hours after retreatment procedures.
An 11-item numerical rating scale (NRS) was used to assess the pain.
This NRS is a segmented numeric version of the visual analog scale (VAS) in which a respondent selects a whole number (0 -10 integers) that best reflects the intensity of their pain.
Number 0 represents 'no pain' whereas number 10 represents 'pain as bad as someone can imagine'.All patients were requested to mark a number corresponding to their average pain.
|
24 hours postoperatively
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Postoperative pain after removal of gutta-percha with or without solvent
Time Frame: 24 to 48 hours postoperatively
|
Pain intensity was evaluated at 48 hours after retreatment procedures.
An 11-item numerical rating scale (NRS) was used to assess the pain.
This NRS is a segmented numeric version of the visual analog scale (VAS) in which a respondent selects a whole number (0 -10 integers) that best reflects the intensity of their pain.
Number 0 represents 'no pain' whereas number 10 represents 'pain as bad as someone can imagine' .
All patients were requested to mark a number corresponding to their average pain.
|
24 to 48 hours postoperatively
|
|
Postoperative pain after removal of gutta-percha with or without solvent
Time Frame: 48 to 72 hours postoperatively
|
Pain intensity was evaluated at 72 hours after retreatment procedures.
An 11-item numerical rating scale (NRS) was used to assess the pain.
This NRS is a segmented numeric version of the visual analog scale (VAS) in which a respondent selects a whole number (0 -10 integers) that best reflects the intensity of their pain.
Number 0 represents 'no pain' whereas number 10 represents 'pain as bad as someone can imagine'.
All patients were requested to mark a number corresponding to their average pain.
|
48 to 72 hours postoperatively
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Ozgur G Genc Sen, Yuzuncu Yil University, Faculty of Dentistry
- Study Director: Ali G Erdemir, Yuzuncu Yil University, Faculty of Dentistry
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- B.30.2.YYU.0.01.00.00/125
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pain
-
Boston Scientific CorporationRecruitingLow Back Pain | Chronic Pain | Chronic Low-back Pain | Leg Pain | Intractable Pain | Chronic Leg PainUnited States
-
Qi's ClinicNot yet recruitingNon-Cancer Pain,Musculoskeletal Pain,Chronic Pain,Acute Pain
-
Flowonix MedicalApproved for marketingBack Pain | Leg Pain | Trunk Pain | Intractable Pain | Arm Pain
-
George Washington UniversityRecruitingCervical Fusion | Pain, Back | Pain, Neck | Myofacial PainUnited States
-
Atatürk Chest Diseases and Chest Surgery Training...RecruitingPostoperative Pain | Postoperative Pain, Acute | Postoperative Pain, Chronic | VATSTurkey
-
Janssen Research & Development, LLCCompletedPain, Radiating | Pain, Burning | Pain, Crushing | Pain, Migratory | Pain, SplittingUnited States, France, Spain, Poland, Portugal
-
susanne beckerSNSFCompletedLow Back Pain | Pain, Acute | Pain, ChronicSwitzerland
-
University Hospital Schleswig-HolsteinZealand University Hospital; European Regional Development Fund; Design School...CompletedPain, Acute | Pain, Chronic | Pain Measurement | Pain, CancerGermany
-
Universitat Jaume ICompletedPain, Acute | Pain, Chronic | OncologySpain
-
Cairo UniversityCompletedCervical Pain | Lumbar Pain SyndromeEgypt
Clinical Trials on Non-solvent
-
Mahidol UniversityCompletedPostoperative Pain | Root Canal | RetreatmentThailand
-
Fujian Medical University Union HospitalRecruitingSkin Wound | Scar, HypertrophicChina
-
Bandim Health ProjectRadboud University Medical CenterCompletedInnate Immunity | Bacille Calmette-GuérinGuinea-Bissau
-
Sun Yat-sen UniversityCompletedHepatocellular CarcinomaChina
-
Liminal BioSciences Ltd.TerminatedHyperammonemiaUnited Kingdom
-
OctapharmaTerminatedThrombotic Thrombocytopenic Purpura (TTP)United States
-
Baxter Healthcare CorporationCompletedHip Replacement SurgeryAustria, Germany, Netherlands
-
St. Olavs HospitalNorwegian University of Science and TechnologyWithdrawnPurpura, Thrombotic Thrombocytopenic
-
Biomedica Foscama S.p.A. Industria Chimico-FarmaceuticaRecruiting
-
Baxter Healthcare CorporationCompletedCardiopulmonary Bypass | Sternotomy | Cardiac Surgery Requiring Cardiopulmonary Bypass and Median SternotomyUnited States